The Food and Drug Administration announced on March 24, 2025, that Boston Scientific Corporation is recalling IceSeed 1.5 CX S NEEDLE OUS cryoablation needles due to programming errors. The agency stated the recall is voluntary and classified as Class II.
How to tell if you have it
- IceSeed 1.5 CX S NEEDLE OUS, Cryoablation Needle, REF H7493967334100
- UPC 00191506032685
- Batch Numbers: 33996437, 33996438, 34295231, 34295232, 34392272, 34392273, 34392274, 34564921
- Manufactured between April 2024 and February 2025
The hazard
According to the FDA, affected needles were programmed with DEMO settings instead of Commercial settings. The needles perform as intended unless disconnected and reconnected after testing, in which case the system prompts a re-execution of the Needle Integrity and Functionality Test.
Context
GovInfoNow's records show Boston Scientific Corporation has 124 other recalls on record since June 1, 2017. Recent recalls include the August 24, 2026, recall of Imager II Angiographic Catheters for tip fracture risk and the August 6, 2026, recall of LUX-Dx Cardiac Monitor Systems for delayed AF burden alerts. Other recent recalls of similar products include the April 29, 2026, CSK Electrodes recall for performance levels, the April 22, 2026, Intracept Access Instruments recall for sterility breach risk, and the April 29, 2026, TCN Electrodes recall for performance issues.